Guangdong Biolight Meditech Co., Ltd. (SHE:300246)

Market Cap	5.64B +235.5%
Revenue (ttm)	1.10B +3.3%
Net Income	-69.43M
EPS	-0.26
Shares Out	261.64M
PE Ratio	n/a
Forward PE	n/a
Dividend	0.10 (0.46%)
Ex-Dividend Date	Nov 26, 2025

Volume	14,267,614
Average Volume	13,449,949
Open	18.76
Previous Close	21.57
Day's Range	18.76 - 21.98
52-Week Range	7.23 - 21.98
Beta	0.71
RSI	74.28
Earnings Date	Apr 25, 2026

About SHE:300246

Guangdong Biolight Meditech Co., Ltd. engages in the research and development, production, sale, and service of medical devices products and solutions in China. It operates in two segments, Life Information and Support, and Kidney Disease. The company offers emergency and critical care monitor, subcritical care monitor, general ward monitor, outpatient monitor, neonatal monitor, infusion pump, electrocardiograph, maternal and fetal monitor, defibrillator, multifunctional suspension device, internet of things, and central station; hemodiafiltrat...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1993
• Employees: 1,335
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300246

Financial Performance

In 2025, SHE:300246's revenue was 1.10 billion, an increase of 3.29% compared to the previous year's 1.06 billion. Losses were -69.43 million, -2.82% less than in 2024.